Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Follow-Up (PMCF) Study of the CLS Brevius Stem With Kinectiv Technology

NCT03410940 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT03410940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03410940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Follow-Up (PMCF) Study of the CLS Brevius Stem With Kinectiv Technology
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Terminated
Start date
January 7, 2011
Completion date
December 14, 2020
Enrollment
223 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, femoral neck fractures, osteoarthritis, prosthesis failure, rheumatoid arthritis